-
Signature
-
/s/ Michelle Gilson, as Attorney-in-Fact
-
Stock symbol
-
ACLX
-
Transactions as of
-
Aug 1, 2024
-
Transactions value $
-
-$989,670
-
Form type
-
4
-
Date filed
-
8/2/2024, 04:02 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ACLX |
Common Stock |
Options Exercise |
$58.5K |
+9.32K |
+100.41% |
$6.28 |
18.6K |
Aug 1, 2024 |
Direct |
|
transaction |
ACLX |
Common Stock |
Options Exercise |
$160K |
+10.7K |
+57.46% |
$15.00 |
29.3K |
Aug 1, 2024 |
Direct |
|
transaction |
ACLX |
Common Stock |
Sale |
-$1.16M |
-19.3K |
-65.81% |
$60.39 |
10K |
Aug 1, 2024 |
Direct |
F1, F2 |
transaction |
ACLX |
Common Stock |
Sale |
-$44.7K |
-732 |
-7.31% |
$61.13 |
9.28K |
Aug 1, 2024 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ACLX |
Stock Option (right to buy) |
Options Exercise |
$0 |
-9.32K |
-14.6% |
$0.00 |
54.5K |
Aug 1, 2024 |
Common Stock |
9.32K |
$6.28 |
Direct |
F4 |
transaction |
ACLX |
Stock Option (right to buy) |
Options Exercise |
$0 |
-10.7K |
-5.62% |
$0.00 |
180K |
Aug 1, 2024 |
Common Stock |
10.7K |
$15.00 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: